Riskpilot← Back to searchSign inGet full accessCapio Medocular AB
ABActiveOrg 5562599430Arenavägen 27Medical specialists activities · NACE 8622Est. 1985120 employees
Revenue 2025
SEK 264M
-9% vs 2024
EBITDA margin
-3.8%
-2% vs 2024
Equity ratio
9.3%
Financial strength
Net profit 2025
SEK 19,8M
120 employees
| Revenue | SEK 264M | -9% |
| EBITDA | SEK -9,9M | -2% |
| Net profit | SEK 19,8M | — |
| Total assets | SEK 284M | +5% |
| Equity | SEK 26,4M | +307% |
| Employees | 120 | — |
Legal name
Capio Medocular AB
Org number
5562599430
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 maj 1985
Share capital
SEK 500 000
Employees
120 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva läkarverksamhet i Sverige och utomlands, medicinsk forskning, planering och utveckling av nya medicinska koncept, undervisning och kapitalförvaltning, ävensom idka därmed förenlig verksamhet.
Address
Arenavägen 27
Phone
+4618565400
Email
info@capiomedocular.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 197 591 | 192 114 | 272 312 | 196 050 | 211 503 | 264 403 | 289 372 | 263 963 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 6 090 | 11 361 | 12 639 | 3 997 | −2 972 | 4 448 | −681 | 1 489 | −9 677 | −9 912 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | 6 090 | 11 361 | 12 639 | 3 997 | −2 972 | 4 448 | −681 | 1 489 | −9 677 | −9 912 |
| Net financials | −184 | −66 | −873 | −1 774 | −44 239 | −2 697 | −5 653 | −35 394 | −12 585 | −14 101 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 836 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 836 |
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 36 343 | 39 409 | 149 820 | 115 420 | 121 902 | 120 649 | 266 006 | 279 938 | 271 531 | 283 952 |
| Equity | 6 452 | 6 453 | 6 453 | 6 453 | 6 453 | 6 453 | 6 453 | 6 453 | 6 470 | 26 360 |
| Long-term debt | 4 500 | 0 | 0 | 0 | 0 | 0 | 230 000 | 230 000 | 230 000 | 230 000 |
| Short-term debt | 25 391 | 32 956 | 143 367 | 108 967 | 115 449 | 114 196 | 29 553 | 43 485 | 35 061 | 27 592 |
| Total debt | 29 891 | 32 956 | 143 367 | 108 967 | 115 449 | 114 196 | 259 553 | 273 485 | 265 061 | 257 592 |
EBITDA margin
-3.8%
This company
15.8%
Market median
-124% vs market
20152025
Equity ratio
9.3%
This company
38.2%
Market median
-76% vs market
20152025
Return on equity
75.3%
This company
18.4%
Market median
+309% vs market
20152025
Net profit margin
7.5%
This company
8.1%
Market median
-7% vs market
20152025
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20152025
Debt / equity
9.77×
This company
0.62×
Market median
-1476% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-01-01 – 2020-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AL External Signatory | External Signatory | 2020 | — | — |
MM External Signatory | External Signatory | 2021 | — | — |
LE Chief Auditor | Chief Auditor | 2022 | — | — |
AU Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MS Audit | Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Capio Specialistkliniker AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Capio AB (publ)
Capio Medocular AB Board members of Capio Medocular AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Lars Rydholm | External Signatory | 0 companies |
| Maria Magdalena Aidanpää | External Signatory | 0 companies |
| Linda Elisabeth Sallander | Chief Auditor | 0 companies |
| Anette U M Wennerberg Johansson | Chief Executive Officer | 0 companies |
| Mikael Sjölander | Audit | 0 companies |
| Bo Peter Holm | Chairman | 0 companies |
| Jens Johnsson | Board of Directors | 0 companies |
| Karl Arne Johansson Bäckgren | Board of Directors | 0 companies |
| Malin Victoria Bohlin | Chairman | 0 companies |
| Karin Astrid Lindh | Board of Directors | 0 companies |